Oxbridge Re Holdings Limited (NASDAQ:OXBR – Get Free Report)’s share price crossed below its fifty day moving average during trading on Thursday . The stock has a fifty day moving average of $0.90 and traded as low as $0.89. Oxbridge Re shares last traded at $0.9199, with a volume of 6,125 shares.
Analysts Set New Price Targets
Separately, Weiss Ratings lowered shares of Oxbridge Re from a “sell (d-)” rating to a “sell (e+)” rating in a research report on Wednesday. One analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the company presently has an average rating of “Sell”.
Read Our Latest Stock Report on OXBR
Oxbridge Re Stock Performance
Oxbridge Re (NASDAQ:OXBR – Get Free Report) last posted its quarterly earnings data on Saturday, February 14th. The insurance provider reported $0.02 earnings per share for the quarter. Oxbridge Re had a negative net margin of 76.47% and a negative return on equity of 33.33%. The company had revenue of $0.58 million during the quarter.
Institutional Trading of Oxbridge Re
A number of hedge funds have recently bought and sold shares of OXBR. Virtu Financial LLC purchased a new stake in shares of Oxbridge Re in the third quarter worth approximately $32,000. International Assets Investment Management LLC purchased a new stake in shares of Oxbridge Re in the fourth quarter worth approximately $39,000. J.W. Cole Advisors Inc. purchased a new stake in shares of Oxbridge Re in the third quarter worth approximately $59,000. Finally, Henrickson Nauta Wealth Advisors Inc. lifted its position in shares of Oxbridge Re by 100.0% in the fourth quarter. Henrickson Nauta Wealth Advisors Inc. now owns 137,400 shares of the insurance provider’s stock worth $185,000 after purchasing an additional 68,700 shares in the last quarter. 5.64% of the stock is owned by hedge funds and other institutional investors.
About Oxbridge Re
Oxbridge Re Holdings Limited (NASDAQ: OXBR) is a reinsurance holding company that provides capital solutions and risk-sharing arrangements to insurance carriers. Its core business centers on offering treaty reinsurance and structured transactions designed to help insurers manage underwriting exposures and optimize their capital efficiency. By leveraging tailored financing structures, Oxbridge Re enables clients to transfer segments of their in-force life and health insurance portfolios, freeing up capital for growth or other strategic initiatives.
The company’s products and services include quota share reinsurance, coinsurance, and loss portfolio transfers, each crafted to address specific balance sheet and earnings targets of cedents.
Further Reading
- Five stocks we like better than Oxbridge Re
- The Great AI Server Rotation Puts Hewlett Packard Enterprise and Super Micro Computer in Focus
- Generac’s AI Power Pivot Raises a Bigger Question About Data Center Demand
- Medtronic Bottoms, Healthy Rebound Ahead
- GitLab’s Price Recovery Gains Traction—Time to Get On Board?
Receive News & Ratings for Oxbridge Re Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxbridge Re and related companies with MarketBeat.com's FREE daily email newsletter.
